Artificial Intelligence

Artificial intelligence (AI) is becoming a crucial component of healthcare to help augment physicians and make them more efficient. In medical imaging, it is helping radiologists more efficiently manage PACS worklists, enable structured reporting, auto detect injuries and diseases, and to pull in relevant prior exams and patient data. In cardiology, AI is helping automate tasks and measurements on imaging and in reporting systems, guides novice echo users to improve imaging and accuracy, and can risk stratify patients. AI includes deep learning algorithms, machine learning, computer-aided detection (CAD) systems, and convolutional neural networks. 

Healthcare IT Outsourcing Market by Application & Industry - Global Forecast To 2018

'Healthcare IT Outsourcing Market - By Application [Provider (EHR, RCM, LIMS) Payer (CRM, Claims Management, Fraud Detection, Billing) Life Science (ERP, CTMS, CDMS) Operational (SCM, BPM) & Infrastructure (IMS, Cloud Computing)] & Industry - Global Forecast To 2018'

As The Countdown To Obamacare Begins, Maryland Company Seeks To Give Patients A Voice In The Debate Over Unifying And Accessing Their Own Health Records

Medical Informatics, Inc., a corporation committed to patient-centered technological innovations, has launched a web-based public education campaign to educate patients regarding the role of unique patient identifiers in identifying patient health records from different sources.  The grassroots effort's vision of "One Patient | One Number | One Card" aims to unify health records from different providers, irrespective of whether they are paper-based or electronic, and give access to those records to the patients themselves.

ConnectedLiving and CDW Healthcare Partner to Get Seniors Online and Connected

QUINCY, Mass., April 29, 2013 -- ConnectedLiving, a mission-based organization helping senior citizens live richer, more connected lives through the use of technology, today announced a partnership with CDW Healthcare, a leading provider of technology solutions for healthcare. Together both organizations will deliver the technology, services and training necessary to get entire senior living communities online.

Philips to distribute Corindus robotic-assisted PCI system

Royal Philips Electronics and Corindus Vascular Robotics have signed a U.S. distribution agreement for Corindus CorPath 200 system, the recently FDA-approved robotic-assisted system to be used during PCI procedures.

Study: Remote robot assistance makes ICU docs happy

Nearly 90 percent of physicians who use rolling robots to remotely treat patients in the ICU do so without additional compensationyet a strong majority, 66 percent, consider the technology a blessing. None perceive such remote presence as a pure burden and, while 33 percent see it as a mixed blessing and burden, fully 100 percent intend to continue using it.

InTouch robots cleared for high-acuity patient monitoring

The FDA has expanded its clearance of InTouch Healths remote-presence monitors to allow use of the telemedicine technology in a number of acute-care environments.

Report: Cultural, reimbursement barriers thwart robotic telemed adoption

Licensing, costs for technology and reimbursement for robotic telemedicine continue to impede progress, according to an article published in the January/February edition of Telemedicine and e-Health.

Study: Robotic telemedicine in NICU feasible, safe

A remote-controlled, robotic telemedicine system in the neonatal intensive care unit (NICU) is feasible and safe, according to a research published in the May editiion of Journal of Perinatology.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.